US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Connect Biopharma Holdings Ltd.

1.79

-0.0600-3.24%

Volume:74.75K

Turnover:136.75K

Market Cap:99.74M

PE:-2.20

High:1.87

Open:1.87

Low:1.72

Close:1.85

52wk High:2.86

52wk Low:0.5100

Shares:55.72M

Float Shares:14.34M

Volume Ratio:0.61

T/O Rate:0.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.8133

EPS(LYR):-0.2830

ROE:-49.45%

ROA:-30.58%

PB:1.40

PE(LYR):-6.32

Loading ...

Overview Company News Filings

Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart

Connect Biopharma presents data on rademikibart at ERS Congress

Connect Biopharma Announces Promising Phase 2 Data for Rademikibart in Asthma and COPD, with Topline Results Expected in 1H 2026

Connect Biopharma Executives Increase Share Holdings

BRIEF-Connect Biopharma Completes Termination Of Its American Depositary Receipt Program And Directly Lists Its Ordinary Shares On Nasdaq

Connect Biopharma Unveils Rademikibart's Promising Potential for Asthma and COPD Treatment in Latest Presentation

Connect Biopharma Completes Termination of Its American Depositary Receipt Program and Directly Lists Its Ordinary Shares on Nasdaq

THOMSON REUTERS

Connect Biopharma Holdings Ltd. Transitions to Direct Nasdaq Listing, Enhancing U.S. Market Focus

Connect Biopharma Holdings Ltd. to Participate in Cantor Global Healthcare and H.C. Wainwright Conferences

Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Connect Biopharma Hldgs Q2 EPS $(0.23) Misses $(0.22) Estimate, Sales $48.000K Down From $24.116M YoY

Connect Biopharma Holdings Ltd. Submits New Drug Application for Rademikibart for AD Treatment to China's NMPA

Connect Biopharma Initiates Phase 2 Seabreeze STAT Studies for Asthma and COPD, Showcasing Promising Data on Rademikibart's Efficacy and Safety

Connect Biopharma Holdings Ltd - Q2 EPS $-0.23

THOMSON REUTERS

Connect Biopharma Holdings Ltd. Appoints Industry Veteran Jim Schoeneck to Board of Directors, Expanding Leadership Team

Connect Biopharma Holdings Ltd. to Terminate ADR Program and Directly List Ordinary Shares on Nasdaq

Connect Biopharma Holdings Ltd. to Participate in BTIG Virtual Biotechnology Conference

Connect Biopharma Regains Nasdaq Compliance with Minimum Bid Price Requirement

Connect Biopharma's Partner Simcere Submits New Drug Application for Rademikibart for Atopic Dermatitis Treatment in China

Connect Biopharma Unveils Promising Data for Rademikibart in Asthma and COPD Phase 2 Studies, Topline Results Expected 1H26

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNTB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNTB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"Connect Biopharma Holdings Ltd.","latestPrice":1.79,"timestamp":1760642653577,"preClose":1.85,"halted":0,"volume":74748,"delay":0,"floatShares":14344108,"shares":55721657,"eps":-0.813269,"marketStatus":"Trading","change":-0.06,"latestTime":"10-16 15:24:53 EDT","open":1.87,"high":1.87,"low":1.72,"amount":136752.96096,"amplitude":0.081081,"askPrice":1.8,"askSize":300,"bidPrice":1.77,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.813269,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1760644800000},"marketStatusCode":2,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":1.85,"preHourTrading":{"tag":"盘前","latestPrice":1.85,"preClose":1.85,"latestTime":"08:20 EDT","volume":200,"amount":370,"timestamp":1760617211858},"postHourTrading":{"tag":"盘后","latestPrice":1.87,"preClose":1.87,"latestTime":"16:10 EDT","volume":1,"amount":1.85,"timestamp":1760559004437},"volumeRatio":0.611146,"impliedVol":1.2915,"impliedVolPercentile":0.896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNTB\",,,,,undefined,":{"symbol":"CNTB","floatShares":14344108,"roa":"-30.58%","roe":"-49.45%","lyrEps":-0.283049,"volumeRatio":0.611146,"shares":55721657,"dividePrice":0,"high":1.87,"amplitude":0.081081,"preClose":1.85,"low":1.72,"week52Low":0.51,"pbRate":"1.40","psRate":"50.76","week52High":2.86,"institutionHeld":0,"latestPrice":1.79,"committee":-0.5,"eps":-0.813269,"divideRate":0,"volume":74748,"delay":0,"ttmEps":-0.813269,"open":1.87,"prevYearClose":1.38,"prevWeekClose":1.86,"prevMonthClose":1.51,"prevQuarterClose":1.51,"fiveDayClose":1.98,"twentyDayClose":1.61,"sixtyDayClose":2.27},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNTB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"CNTB","fiscalQuarterEnding":"2025/06","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2025-05-15","symbol":"CNTB","fiscalQuarterEnding":"2025/03","expectedEps":-0.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.19},{"date":"2025-03-31","symbol":"CNTB","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743408000000,"name":null,"time":"Pre-Market","dateTimestamp":1743393600000,"actualEps":null},{"date":"2024-09-05","symbol":"CNTB","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1725566400000,"name":null,"time":"Post Market","dateTimestamp":1725508800000,"actualEps":null},{"market":"US","date":"2024-04-16","symbol":"CNTB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1713240000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNTB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNTB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1753243200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNTB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNTB","date":"2025-10-15","current":-2.283992,"percent":0.344365,"low":-12.632535,"twenty":-3.178787,"median":-1.01194,"eighty":-0.50825,"high":-0.159163,"avg":-2.21348,"sd":2.493672,"marketCap":101413415},"quantilePoints":[{"date":"2021-03-19","current":-8.225201,"twenty":-7.997774,"median":-7.656633,"eighty":-7.655009,"marketCap":984650040},{"date":"2021-03-26","current":-7.10826,"twenty":-7.997774,"median":-7.561124,"eighty":-7.121039,"marketCap":846724480},{"date":"2021-04-01","current":-8.009059,"twenty":-8.181973,"median":-7.567257,"eighty":-7.178084,"marketCap":950568049},{"date":"2021-04-09","current":-7.612804,"twenty":-8.0273,"median":-7.632136,"eighty":-7.332162,"marketCap":905302904},{"date":"2021-04-16","current":-7.696063,"twenty":-7.97235,"median":-7.643031,"eighty":-7.367612,"marketCap":919681244},{"date":"2021-04-23","current":-7.156707,"twenty":-7.817836,"median":-7.629019,"eighty":-7.367612,"marketCap":858440165},{"date":"2021-04-30","current":-7.199728,"twenty":-7.771758,"median":-7.587406,"eighty":-7.165311,"marketCap":866428132},{"date":"2021-05-07","current":-6.8278,"twenty":-7.707419,"median":-7.579293,"eighty":-7.142023,"marketCap":827020829},{"date":"2021-05-14","current":-7.219178,"twenty":-7.690632,"median":-7.454798,"eighty":-7.108845,"marketCap":873883567},{"date":"2021-05-21","current":-6.833256,"twenty":-7.666455,"median":-7.329594,"eighty":-7.106536,"marketCap":827553360},{"date":"2021-05-28","current":-6.476128,"twenty":-7.656092,"median":-7.217636,"eighty":-6.852745,"marketCap":792406306},{"date":"2021-06-04","current":-6.472584,"twenty":-7.653926,"median":-7.178218,"eighty":-6.8278,"marketCap":788678588},{"date":"2021-06-11","current":-7.871174,"twenty":-7.66891,"median":-7.199728,"eighty":-6.8278,"marketCap":958556016},{"date":"2021-06-18","current":-7.761814,"twenty":-7.761814,"median":-7.272517,"eighty":-6.833256,"marketCap":937254771},{"date":"2021-06-25","current":-8.391559,"twenty":-7.85715,"median":-7.342434,"eighty":-6.834202,"marketCap":1012874190},{"date":"2021-07-02","current":-8.71754,"twenty":-7.959493,"median":-7.474455,"eighty":-6.847608,"marketCap":1049618837},{"date":"2021-07-09","current":-9.134734,"twenty":-8.156045,"median":-7.580053,"eighty":-6.868157,"marketCap":1098611700},{"date":"2021-07-16","current":-9.741359,"twenty":-8.289207,"median":-7.588517,"eighty":-6.907112,"marketCap":1171568464},{"date":"2021-07-23","current":-11.516599,"twenty":-8.530315,"median":-7.620912,"eighty":-6.924109,"marketCap":1384580912},{"date":"2021-07-30","current":-9.719612,"twenty":-8.829681,"median":-7.653926,"eighty":-7.067431,"marketCap":1172100995},{"date":"2021-08-06","current":-9.614005,"twenty":-9.492154,"median":-7.682486,"eighty":-7.105429,"marketCap":1155592530},{"date":"2021-08-13","current":-10.407078,"twenty":-9.721345,"median":-7.761814,"eighty":-7.107829,"marketCap":1251980663},{"date":"2021-08-20","current":-9.903891,"twenty":-9.749231,"median":-7.806323,"eighty":-7.110602,"marketCap":1187011866},{"date":"2021-08-27","current":-8.014295,"twenty":-9.749231,"median":-7.866236,"eighty":-7.118423,"marketCap":964946389},{"date":"2021-09-03","current":-5.186666,"twenty":-9.732952,"median":-7.841331,"eighty":-7.105429,"marketCap":1322919109},{"date":"2021-09-10","current":-4.62158,"twenty":-9.729307,"median":-7.778196,"eighty":-6.898658,"marketCap":1180817978},{"date":"2021-09-17","current":-4.801642,"twenty":-9.723079,"median":-7.710258,"eighty":-6.831074,"marketCap":1222705998},{"date":"2021-09-24","current":-4.489307,"twenty":-9.696523,"median":-7.662771,"eighty":-6.554186,"marketCap":1143171783},{"date":"2021-10-01","current":-4.843137,"twenty":-9.645339,"median":-7.632136,"eighty":-6.431352,"marketCap":1237022157},{"date":"2021-10-08","current":-3.807848,"twenty":-9.620408,"median":-7.603768,"eighty":-6.251971,"marketCap":972968563},{"date":"2021-10-15","current":-3.558007,"twenty":-9.616281,"median":-7.586295,"eighty":-5.019272,"marketCap":910401647},{"date":"2021-10-22","current":-3.355537,"twenty":-9.566602,"median":-7.52994,"eighty":-4.833909,"marketCap":865332259},{"date":"2021-10-29","current":-3.267452,"twenty":-9.502865,"median":-7.441275,"eighty":-4.780728,"marketCap":839881310},{"date":"2021-11-05","current":-3.253783,"twenty":-9.469894,"median":-7.327725,"eighty":-4.593046,"marketCap":837230169},{"date":"2021-11-12","current":-2.966436,"twenty":-9.453591,"median":-7.216094,"eighty":-4.483697,"marketCap":765649376},{"date":"2021-11-19","current":-1.053194,"twenty":-9.259982,"median":-7.152997,"eighty":-4.330678,"marketCap":271476787},{"date":"2021-11-26","current":-0.926282,"twenty":-9.13122,"median":-7.138841,"eighty":-4.174663,"marketCap":238602645},{"date":"2021-12-03","current":-0.915809,"twenty":-9.086801,"median":-7.12805,"eighty":-3.589981,"marketCap":236481732},{"date":"2021-12-10","current":-0.890151,"twenty":-8.969361,"median":-7.109723,"eighty":-3.473393,"marketCap":230118995},{"date":"2021-12-17","current":-0.932161,"twenty":-8.830139,"median":-7.102727,"eighty":-3.378137,"marketCap":240723557},{"date":"2021-12-23","current":-0.943664,"twenty":-8.746242,"median":-6.915567,"eighty":-3.258613,"marketCap":243904926},{"date":"2021-12-31","current":-1.05356,"twenty":-8.697693,"median":-6.840905,"eighty":-3.199128,"marketCap":273067471},{"date":"2022-01-07","current":-0.946776,"twenty":-8.615675,"median":-6.8278,"eighty":-2.990554,"marketCap":244435154},{"date":"2022-01-14","current":-1.051564,"twenty":-8.586449,"median":-6.62613,"eighty":-2.739352,"marketCap":272537243},{"date":"2022-01-21","current":-1.000269,"twenty":-8.511604,"median":-6.513569,"eighty":-2.490275,"marketCap":259811769},{"date":"2022-01-28","current":-0.878785,"twenty":-8.391559,"median":-6.439938,"eighty":-1.053194,"marketCap":227467854},{"date":"2022-02-04","current":-1.01194,"twenty":-8.317939,"median":-6.3296,"eighty":-1.046595,"marketCap":261932681},{"date":"2022-02-11","current":-0.914897,"twenty":-8.307941,"median":-6.197118,"eighty":-1.013637,"marketCap":237011960},{"date":"2022-02-18","current":-0.918769,"twenty":-8.284524,"median":-5.043435,"eighty":-1.005795,"marketCap":239132873},{"date":"2022-02-25","current":-0.764942,"twenty":-8.278042,"median":-5.000788,"eighty":-0.982029,"marketCap":199365765},{"date":"2022-03-04","current":-0.826184,"twenty":-8.235445,"median":-4.843137,"eighty":-0.964922,"marketCap":215272608},{"date":"2022-03-11","current":-0.634904,"twenty":-8.186332,"median":-4.812188,"eighty":-0.954055,"marketCap":164900939},{"date":"2022-03-18","current":-1.01402,"twenty":-8.156045,"median":-4.749358,"eighty":-0.948264,"marketCap":262462909},{"date":"2022-03-25","current":-0.633398,"twenty":-8.055669,"median":-4.610802,"eighty":-0.938787,"marketCap":163840482},{"date":"2022-04-01","current":-0.817881,"twenty":-8.017808,"median":-4.56151,"eighty":-0.931801,"marketCap":167982772},{"date":"2022-04-08","current":-0.769746,"twenty":-8.010106,"median":-4.482295,"eighty":-0.925482,"marketCap":158069035},{"date":"2022-04-14","current":-0.768664,"twenty":-7.979319,"median":-4.405731,"eighty":-0.918413,"marketCap":157518272},{"date":"2022-04-22","current":-0.739819,"twenty":-7.913151,"median":-4.287019,"eighty":-0.914458,"marketCap":148706061},{"date":"2022-04-29","current":-0.56539,"twenty":-7.875607,"median":-4.176153,"eighty":-0.900786,"marketCap":111804927},{"date":"2022-05-06","current":-0.17557,"twenty":-7.868211,"median":-3.670547,"eighty":-0.888287,"marketCap":34417191},{"date":"2022-05-13","current":-0.214562,"twenty":-7.860784,"median":-3.53283,"eighty":-0.874894,"marketCap":41307239},{"date":"2022-05-20","current":-0.256686,"twenty":-7.838167,"median":-3.475686,"eighty":-0.852444,"marketCap":50119450},{"date":"2022-05-27","current":-0.239989,"twenty":-7.802485,"median":-3.447182,"eighty":-0.827995,"marketCap":46814871},{"date":"2022-06-03","current":-0.222507,"twenty":-7.779984,"median":-3.383787,"eighty":-0.815856,"marketCap":43658998},{"date":"2022-06-10","current":-0.234674,"twenty":-7.766282,"median":-3.267452,"eighty":-0.803106,"marketCap":45713344},{"date":"2022-06-17","current":-0.214333,"twenty":-7.741192,"median":-3.248328,"eighty":-0.783474,"marketCap":41701960},{"date":"2022-06-24","current":-0.253451,"twenty":-7.707419,"median":-3.211747,"eighty":-0.770941,"marketCap":49514201},{"date":"2022-07-01","current":-0.255161,"twenty":-7.690632,"median":-3.158228,"eighty":-0.76458,"marketCap":49761772},{"date":"2022-07-08","current":-0.245152,"twenty":-7.66891,"median":-2.966436,"eighty":-0.74871,"marketCap":47863727},{"date":"2022-07-15","current":-0.258726,"twenty":-7.656633,"median":-2.926464,"eighty":-0.68542,"marketCap":50036851},{"date":"2022-07-22","current":-0.234638,"twenty":-7.653926,"median":-2.676357,"eighty":-0.656046,"marketCap":45415525},{"date":"2022-07-29","current":-0.231464,"twenty":-7.632136,"median":-1.85068,"eighty":-0.633398,"marketCap":44848863},{"date":"2022-08-05","current":-0.375753,"twenty":-7.629019,"median":-1.05356,"eighty":-0.56539,"marketCap":72620828},{"date":"2022-08-12","current":-0.397407,"twenty":-7.612804,"median":-1.051572,"eighty":-0.51804,"marketCap":77022090},{"date":"2022-08-19","current":-0.393211,"twenty":-7.594732,"median":-1.046595,"eighty":-0.451463,"marketCap":75371617},{"date":"2022-08-26","current":-0.428161,"twenty":-7.588517,"median":-1.025955,"eighty":-0.413444,"marketCap":81423352},{"date":"2022-09-02","current":-0.389232,"twenty":-7.586295,"median":-1.013637,"eighty":-0.408638,"marketCap":73721143},{"date":"2022-09-09","current":-0.408187,"twenty":-7.581909,"median":-1.011955,"eighty":-0.403502,"marketCap":77022090},{"date":"2022-09-16","current":-0.723373,"twenty":-7.579597,"median":-1.003032,"eighty":-0.405606,"marketCap":79222721},{"date":"2022-09-23","current":-0.60438,"twenty":-7.500328,"median":-0.983258,"eighty":-0.407767,"marketCap":64918619},{"date":"2022-09-30","current":-0.659467,"twenty":-7.470775,"median":-0.967989,"eighty":-0.408548,"marketCap":70970354},{"date":"2022-10-07","current":-0.552143,"twenty":-7.446684,"median":-0.964367,"eighty":-0.409978,"marketCap":59417041},{"date":"2022-10-14","current":-0.488722,"twenty":-7.362202,"median":-0.955013,"eighty":-0.410887,"marketCap":52033923},{"date":"2022-10-21","current":-0.475948,"twenty":-7.332162,"median":-0.951472,"eighty":-0.412961,"marketCap":50328434},{"date":"2022-10-28","current":-0.454861,"twenty":-7.326603,"median":-0.94522,"eighty":-0.415335,"marketCap":48017771},{"date":"2022-11-04","current":-0.373701,"twenty":-7.240513,"median":-0.939366,"eighty":-0.415335,"marketCap":39831423},{"date":"2022-11-11","current":-0.352484,"twenty":-7.216711,"median":-0.934342,"eighty":-0.408548,"marketCap":37971890},{"date":"2022-11-18","current":-0.377052,"twenty":-7.203001,"median":-0.930363,"eighty":-0.402747,"marketCap":40546629},{"date":"2022-11-25","current":-0.382688,"twenty":-7.173915,"median":-0.926282,"eighty":-0.397285,"marketCap":40860219},{"date":"2022-12-02","current":-0.361406,"twenty":-7.152256,"median":-0.920821,"eighty":-0.383534,"marketCap":39418805},{"date":"2022-12-09","current":-0.358359,"twenty":-7.143839,"median":-0.918109,"eighty":-0.380898,"marketCap":39440811},{"date":"2022-12-16","current":-0.350715,"twenty":-7.138568,"median":-0.915353,"eighty":-0.380898,"marketCap":38516546},{"date":"2022-12-23","current":-0.379125,"twenty":-7.1364,"median":-0.908751,"eighty":-0.378676,"marketCap":41542469},{"date":"2022-12-30","current":-0.430096,"twenty":-7.13263,"median":-0.90479,"eighty":-0.377809,"marketCap":47742693},{"date":"2023-01-06","current":-0.417597,"twenty":-7.126486,"median":-0.891571,"eighty":-0.378227,"marketCap":46763412},{"date":"2023-01-13","current":-0.476852,"twenty":-7.118423,"median":-0.887821,"eighty":-0.379443,"marketCap":54410605},{"date":"2023-01-20","current":-0.526363,"twenty":-7.111187,"median":-0.881989,"eighty":-0.380713,"marketCap":59417041},{"date":"2023-01-27","current":-0.623924,"twenty":-7.10826,"median":-0.873573,"eighty":-0.381022,"marketCap":70420197},{"date":"2023-02-03","current":-0.558865,"twenty":-7.106105,"median":-0.856826,"eighty":-0.38112,"marketCap":63273647},{"date":"2023-02-10","current":-0.54294,"twenty":-7.102727,"median":-0.842419,"eighty":-0.381865,"marketCap":61067514},{"date":"2023-02-17","current":-0.528021,"twenty":-6.926245,"median":-0.827693,"eighty":-0.382688,"marketCap":58866883},{"date":"2023-02-24","current":-0.569815,"twenty":-6.917703,"median":-0.817662,"eighty":-0.383186,"marketCap":62717988},{"date":"2023-03-03","current":-0.610413,"twenty":-6.881749,"median":-0.808922,"eighty":-0.383608,"marketCap":67669408},{"date":"2023-03-10","current":-0.527318,"twenty":-6.852745,"median":-0.803422,"eighty":-0.384285,"marketCap":58316725},{"date":"2023-03-17","current":-0.544298,"twenty":-6.836883,"median":-0.794928,"eighty":-0.388273,"marketCap":60517356},{"date":"2023-03-24","current":-0.473741,"twenty":-6.833445,"median":-0.778365,"eighty":-0.390596,"marketCap":52815147},{"date":"2023-03-31","current":-0.493552,"twenty":-6.828891,"median":-0.769746,"eighty":-0.391232,"marketCap":55010277},{"date":"2023-04-06","current":-0.52866,"twenty":-6.807965,"median":-0.768585,"eighty":-0.392449,"marketCap":58866883},{"date":"2023-04-14","current":-0.536009,"twenty":-6.73547,"median":-0.762362,"eighty":-0.395546,"marketCap":62196609},{"date":"2023-04-21","current":-0.498318,"twenty":-6.612165,"median":-0.74871,"eighty":-0.397285,"marketCap":57793309},{"date":"2023-04-28","current":-0.497275,"twenty":-6.553128,"median":-0.731818,"eighty":-0.399415,"marketCap":57242896},{"date":"2023-05-05","current":-0.544069,"twenty":-6.506081,"median":-0.709336,"eighty":-0.401809,"marketCap":62747021},{"date":"2023-05-11","current":-0.556594,"twenty":-6.47471,"median":-0.701012,"eighty":-0.40263,"marketCap":63847846},{"date":"2023-05-19","current":-0.588283,"twenty":-6.459526,"median":-0.687882,"eighty":-0.403154,"marketCap":66599908},{"date":"2023-05-26","current":-0.566751,"twenty":-6.431352,"median":-0.678549,"eighty":-0.404244,"marketCap":63847846},{"date":"2023-06-02","current":-0.543961,"twenty":-6.418474,"median":-0.672932,"eighty":-0.405096,"marketCap":61095784},{"date":"2023-06-08","current":-0.554893,"twenty":-6.355881,"median":-0.659873,"eighty":-0.40589,"marketCap":62196609},{"date":"2023-06-16","current":-0.497477,"twenty":-6.327473,"median":-0.655458,"eighty":-0.407348,"marketCap":55591659},{"date":"2023-06-23","current":-0.614773,"twenty":-6.306796,"median":-0.649124,"eighty":-0.408367,"marketCap":68251146},{"date":"2023-06-30","current":-0.555865,"twenty":-6.294625,"median":-0.644385,"eighty":-0.408548,"marketCap":61095784},{"date":"2023-07-06","current":-0.575855,"twenty":-6.270255,"median":-0.64183,"eighty":-0.408973,"marketCap":63297434},{"date":"2023-07-14","current":-0.558006,"twenty":-6.197118,"median":-0.634151,"eighty":-0.410313,"marketCap":62196609},{"date":"2023-07-21","current":-0.535216,"twenty":-5.186666,"median":-0.627919,"eighty":-0.411031,"marketCap":59444546},{"date":"2023-07-28","current":-0.495387,"twenty":-5.058382,"median":-0.626447,"eighty":-0.411478,"marketCap":55041247},{"date":"2023-08-04","current":-0.475069,"twenty":-5.028488,"median":-0.624235,"eighty":-0.413444,"marketCap":52839597},{"date":"2023-08-11","current":-0.463522,"twenty":-5.005447,"median":-0.623221,"eighty":-0.415808,"marketCap":51188359},{"date":"2023-08-18","current":-0.453142,"twenty":-4.996129,"median":-0.614773,"eighty":-0.416116,"marketCap":49537122},{"date":"2023-08-25","current":-0.412067,"twenty":-4.883081,"median":-0.606902,"eighty":-0.415808,"marketCap":45133822},{"date":"2023-09-01","current":-0.413906,"twenty":-4.843137,"median":-0.600278,"eighty":-0.412385,"marketCap":45453061},{"date":"2023-09-08","current":-0.394786,"twenty":-4.824681,"median":-0.597524,"eighty":-0.411389,"marketCap":42937676},{"date":"2023-09-15","current":-0.553612,"twenty":-4.814942,"median":-0.596714,"eighty":-0.410887,"marketCap":46234647},{"date":"2023-09-22","current":-0.431749,"twenty":-4.811303,"median":-0.589983,"eighty":-0.411389,"marketCap":35906656},{"date":"2023-09-29","current":-0.493437,"twenty":-4.803456,"median":-0.588992,"eighty":-0.411949,"marketCap":41072368},{"date":"2023-10-06","current":-0.621906,"twenty":-4.759815,"median":-0.589869,"eighty":-0.412067,"marketCap":51767265},{"date":"2023-10-13","current":-0.582179,"twenty":-4.685168,"median":-0.589926,"eighty":-0.412321,"marketCap":48462971},{"date":"2023-10-20","current":-0.782186,"twenty":-4.631088,"median":-0.595176,"eighty":-0.412783,"marketCap":64984439},{"date":"2023-10-27","current":-0.758864,"twenty":-4.617269,"median":-0.595506,"eighty":-0.412995,"marketCap":63034906},{"date":"2023-11-03","current":-0.92881,"twenty":-4.596535,"median":-0.597168,"eighty":-0.413536,"marketCap":77155254},{"date":"2023-11-10","current":-1.055984,"twenty":-4.578364,"median":-0.598624,"eighty":-0.414286,"marketCap":88114494},{"date":"2023-11-17","current":-1.305878,"twenty":-4.558808,"median":-0.604483,"eighty":-0.41587,"marketCap":109592402},{"date":"2023-11-24","current":-0.835288,"twenty":-4.548002,"median":-0.609664,"eighty":-0.416116,"marketCap":71042311},{"date":"2023-12-01","current":-0.74365,"twenty":-4.489307,"median":-0.614773,"eighty":-0.417326,"marketCap":63332292},{"date":"2023-12-08","current":-0.602179,"twenty":-4.475282,"median":-0.621384,"eighty":-0.417597,"marketCap":51216549},{"date":"2023-12-15","current":-0.49234,"twenty":-4.418471,"median":-0.610413,"eighty":-0.420523,"marketCap":42135249},{"date":"2023-12-22","current":-0.537452,"twenty":-4.392992,"median":-0.609656,"eighty":-0.421884,"marketCap":45742436},{"date":"2023-12-29","current":-0.708246,"twenty":-4.373067,"median":-0.609218,"eighty":-0.423709,"marketCap":60578714},{"date":"2024-01-05","current":-0.789997,"twenty":-4.345231,"median":-0.610101,"eighty":-0.424968,"marketCap":67187301},{"date":"2024-01-12","current":-0.739514,"twenty":-4.284263,"median":-0.614773,"eighty":-0.42546,"marketCap":62924763},{"date":"2024-01-19","current":-0.697741,"twenty":-4.273239,"median":-0.621906,"eighty":-0.426746,"marketCap":58926568},{"date":"2024-01-26","current":-0.841231,"twenty":-4.183606,"median":-0.623949,"eighty":-0.427141,"marketCap":71593026},{"date":"2024-02-02","current":-0.65717,"twenty":-4.168701,"median":-0.625511,"eighty":-0.428161,"marketCap":55622274},{"date":"2024-02-09","current":-0.719854,"twenty":-3.807848,"median":-0.627255,"eighty":-0.430096,"marketCap":61129430},{"date":"2024-02-16","current":-0.785847,"twenty":-3.670547,"median":-0.628587,"eighty":-0.430295,"marketCap":66636586},{"date":"2024-02-23","current":-0.703977,"twenty":-3.644463,"median":-0.629181,"eighty":-0.430329,"marketCap":59477283},{"date":"2024-03-01","current":-0.768787,"twenty":-3.573994,"median":-0.637061,"eighty":-0.431467,"marketCap":64984439},{"date":"2024-03-08","current":-0.782256,"twenty":-3.517724,"median":-0.642819,"eighty":-0.432231,"marketCap":66096885},{"date":"2024-03-15","current":-0.730103,"twenty":-3.500919,"median":-0.648502,"eighty":-0.435038,"marketCap":61680146},{"date":"2024-03-22","current":-0.808945,"twenty":-3.480396,"median":-0.652377,"eighty":-0.435836,"marketCap":68288733},{"date":"2024-03-28","current":-1.054383,"twenty":-3.473393,"median":-0.654869,"eighty":-0.436123,"marketCap":88665209},{"date":"2024-04-05","current":-1.179969,"twenty":-3.465214,"median":-0.658098,"eighty":-0.440275,"marketCap":99128806},{"date":"2024-04-12","current":-1.259189,"twenty":-3.444462,"median":-0.660278,"eighty":-0.443139,"marketCap":105737393},{"date":"2024-04-19","current":-1.407563,"twenty":-3.420656,"median":-0.672034,"eighty":-0.443489,"marketCap":83754210},{"date":"2024-04-26","current":-1.259398,"twenty":-3.378137,"median":-0.676202,"eighty":-0.44479,"marketCap":74937977},{"date":"2024-05-03","current":-1.435344,"twenty":-3.320017,"median":-0.681097,"eighty":-0.44561,"marketCap":85407253},{"date":"2024-05-10","current":-1.32422,"twenty":-3.279006,"median":-0.684378,"eighty":-0.446408,"marketCap":78795079},{"date":"2024-05-17","current":-1.592768,"twenty":-3.260823,"median":-0.693504,"eighty":-0.447635,"marketCap":94774500},{"date":"2024-05-24","current":-1.666851,"twenty":-3.254831,"median":-0.701012,"eighty":-0.448794,"marketCap":99182617},{"date":"2024-05-31","current":-1.449234,"twenty":-3.249419,"median":-0.704085,"eighty":-0.449278,"marketCap":86233775},{"date":"2024-06-07","current":-1.518686,"twenty":-3.238835,"median":-0.706334,"eighty":-0.4494,"marketCap":90366384},{"date":"2024-06-14","current":-1.555727,"twenty":-3.224366,"median":-0.708791,"eighty":-0.449677,"marketCap":92570442},{"date":"2024-06-21","current":-1.340148,"twenty":-3.190715,"median":-0.71884,"eighty":-0.450315,"marketCap":79742824},{"date":"2024-06-28","current":-1.185316,"twenty":-3.183833,"median":-0.721224,"eighty":-0.450774,"marketCap":70529861},{"date":"2024-07-05","current":-1.240878,"twenty":-3.170454,"median":-0.723582,"eighty":-0.451545,"marketCap":73835948},{"date":"2024-07-12","current":-1.176056,"twenty":-3.143988,"median":-0.729841,"eighty":-0.451982,"marketCap":69978846},{"date":"2024-07-15","current":-1.157535,"twenty":-3.129748,"median":-0.729947,"eighty":-0.452091,"marketCap":68876817},{"date":"2024-08-02","current":-1.092713,"twenty":-3.115508,"median":-0.730052,"eighty":-0.452201,"marketCap":65019715},{"date":"2024-08-09","current":-0.98159,"twenty":-3.014673,"median":-0.736133,"eighty":-0.452774,"marketCap":58407541},{"date":"2024-08-16","current":-1.092713,"twenty":-2.961387,"median":-0.739819,"eighty":-0.45309,"marketCap":65019715},{"date":"2024-08-23","current":-0.935288,"twenty":-2.949349,"median":-0.74874,"eighty":-0.453588,"marketCap":55652468},{"date":"2024-08-30","current":-1.185316,"twenty":-2.923043,"median":-0.750977,"eighty":-0.454471,"marketCap":70529861},{"date":"2024-09-06","current":-1.101881,"twenty":-2.824357,"median":-0.754751,"eighty":-0.455485,"marketCap":65565220},{"date":"2024-09-13","current":-3.101255,"twenty":-3.038791,"median":-0.760755,"eighty":-0.458405,"marketCap":66304838},{"date":"2024-09-20","current":-3.20308,"twenty":-3.135439,"median":-0.764942,"eighty":-0.461887,"marketCap":68481847},{"date":"2024-09-27","current":-3.643975,"twenty":-3.178787,"median":-0.768625,"eighty":-0.462897,"marketCap":77908185},{"date":"2024-10-04","current":-3.786116,"twenty":-3.214164,"median":-0.768787,"eighty":-0.463358,"marketCap":80947156},{"date":"2024-10-11","current":-3.256318,"twenty":-3.2512,"median":-0.769748,"eighty":-0.463499,"marketCap":69620080},{"date":"2024-10-18","current":-3.20463,"twenty":-3.255304,"median":-0.777696,"eighty":-0.46412,"marketCap":68514999},{"date":"2024-10-25","current":-3.152943,"twenty":-3.2512,"median":-0.778868,"eighty":-0.46532,"marketCap":67409919},{"date":"2024-10-31","current":-3.023724,"twenty":-3.252492,"median":-0.779597,"eighty":-0.466029,"marketCap":64647217},{"date":"2024-11-08","current":-2.920349,"twenty":-3.246435,"median":-0.78225,"eighty":-0.467418,"marketCap":62437056},{"date":"2024-11-15","current":-2.558536,"twenty":-3.240854,"median":-0.784347,"eighty":-0.469438,"marketCap":54701491},{"date":"2024-11-22","current":-2.558794,"twenty":-3.232318,"median":-0.791102,"eighty":-0.471718,"marketCap":54707017},{"date":"2024-11-29","current":-2.739442,"twenty":-3.230474,"median":-0.795022,"eighty":-0.47267,"marketCap":58569273},{"date":"2024-12-06","current":-2.584379,"twenty":-3.230474,"median":-0.797467,"eighty":-0.473741,"marketCap":55254032},{"date":"2024-12-13","current":-2.972036,"twenty":-3.221554,"median":-0.799781,"eighty":-0.47387,"marketCap":63542136},{"date":"2024-12-20","current":-2.564997,"twenty":-3.20463,"median":-0.803647,"eighty":-0.474921,"marketCap":54839626},{"date":"2024-12-27","current":-2.506848,"twenty":-3.20463,"median":-0.806207,"eighty":-0.475039,"marketCap":53596411},{"date":"2025-01-03","current":-3.127099,"twenty":-3.2114,"median":-0.808052,"eighty":-0.475596,"marketCap":66857378},{"date":"2025-01-10","current":-2.881583,"twenty":-3.20463,"median":-0.808945,"eighty":-0.47631,"marketCap":61608245},{"date":"2025-01-17","current":-2.698092,"twenty":-3.20463,"median":-0.815352,"eighty":-0.478446,"marketCap":57685209},{"date":"2025-01-24","current":-2.765286,"twenty":-3.20432,"median":-0.816837,"eighty":-0.481062,"marketCap":59121814},{"date":"2025-01-31","current":-2.506848,"twenty":-3.200607,"median":-0.819848,"eighty":-0.481972,"marketCap":53596411},{"date":"2025-02-07","current":-2.713598,"twenty":-3.188329,"median":-0.826287,"eighty":-0.482087,"marketCap":58016733},{"date":"2025-02-14","current":-2.506848,"twenty":-3.178787,"median":-0.830851,"eighty":-0.482431,"marketCap":53596411},{"date":"2025-02-21","current":-2.222566,"twenty":-3.178787,"median":-0.833977,"eighty":-0.482982,"marketCap":47518467},{"date":"2025-02-28","current":-2.323357,"twenty":-3.178787,"median":-0.836434,"eighty":-0.483597,"marketCap":49673374},{"date":"2025-03-07","current":-2.145035,"twenty":-3.178787,"median":-0.841825,"eighty":-0.483604,"marketCap":45860846},{"date":"2025-03-14","current":-2.196464,"twenty":-3.17351,"median":-0.847958,"eighty":-0.485805,"marketCap":46960401},{"date":"2025-03-21","current":-2.132888,"twenty":-3.158228,"median":-0.854887,"eighty":-0.486637,"marketCap":45601152},{"date":"2025-03-28","current":-1.964128,"twenty":-3.152943,"median":-0.866854,"eighty":-0.487368,"marketCap":41993064},{"date":"2025-04-04","current":-2.085992,"twenty":-3.152943,"median":-0.871306,"eighty":-0.488722,"marketCap":32599878},{"date":"2025-04-11","current":-2.262418,"twenty":-3.152943,"median":-0.875775,"eighty":-0.489198,"marketCap":35357074},{"date":"2025-04-17","current":-2.939585,"twenty":-3.152943,"median":-0.881739,"eighty":-0.490836,"marketCap":45939842},{"date":"2025-04-25","current":-2.739481,"twenty":-3.132268,"median":-0.886194,"eighty":-0.49207,"marketCap":42812612},{"date":"2025-05-02","current":-2.904169,"twenty":-3.127099,"median":-0.891223,"eighty":-0.492327,"marketCap":45386350},{"date":"2025-05-09","current":-2.798273,"twenty":-3.106424,"median":-0.899784,"eighty":-0.492888,"marketCap":43731409},{"date":"2025-05-16","current":-2.338518,"twenty":-3.101255,"median":-0.908751,"eighty":-0.493355,"marketCap":40238874},{"date":"2025-05-23","current":-2.650534,"twenty":-3.101255,"median":-0.914348,"eighty":-0.493529,"marketCap":45607747},{"date":"2025-05-30","current":-2.509001,"twenty":-3.092719,"median":-0.916163,"eighty":-0.493996,"marketCap":43172382},{"date":"2025-06-06","current":-2.518927,"twenty":-3.072615,"median":-0.918616,"eighty":-0.494949,"marketCap":43343179},{"date":"2025-06-13","current":-2.744633,"twenty":-3.062696,"median":-0.921672,"eighty":-0.495485,"marketCap":47226897},{"date":"2025-06-20","current":-3.229303,"twenty":-3.095564,"median":-0.926208,"eighty":-0.496241,"marketCap":55566612},{"date":"2025-06-27","current":-3.133725,"twenty":-3.101255,"median":-0.92807,"eighty":-0.497308,"marketCap":53922004},{"date":"2025-07-03","current":-3.775646,"twenty":-3.1324,"median":-0.930363,"eighty":-0.497381,"marketCap":64967542},{"date":"2025-07-11","current":-3.713327,"twenty":-3.152943,"median":-0.93415,"eighty":-0.497487,"marketCap":63895214},{"date":"2025-07-18","current":-6.005902,"twenty":-3.164335,"median":-0.936471,"eighty":-0.497685,"marketCap":103343564},{"date":"2025-07-25","current":-7.588103,"twenty":-3.178787,"median":-0.942975,"eighty":-0.498434,"marketCap":130568481},{"date":"2025-08-01","current":-6.522539,"twenty":-3.20432,"median":-0.946493,"eighty":-0.498956,"marketCap":112233333},{"date":"2025-08-08","current":-6.683988,"twenty":-3.227495,"median":-0.950054,"eighty":-0.499577,"marketCap":115011385},{"date":"2025-08-15","current":-2.66504,"twenty":-3.229238,"median":-0.954196,"eighty":-0.501376,"marketCap":119801562},{"date":"2025-08-22","current":-2.144428,"twenty":-3.227495,"median":-0.96009,"eighty":-0.50282,"marketCap":96398466},{"date":"2025-08-29","current":-2.181614,"twenty":-3.218169,"median":-0.964367,"eighty":-0.504694,"marketCap":98070116},{"date":"2025-09-05","current":-2.206406,"twenty":-3.20463,"median":-0.967699,"eighty":-0.50475,"marketCap":99184549},{"date":"2025-09-12","current":-2.020472,"twenty":-3.20463,"median":-0.970171,"eighty":-0.505978,"marketCap":90826300},{"date":"2025-09-19","current":-1.995681,"twenty":-3.20463,"median":-0.977113,"eighty":-0.50622,"marketCap":89711867},{"date":"2025-09-26","current":-2.094846,"twenty":-3.20308,"median":-0.986053,"eighty":-0.507063,"marketCap":94169600},{"date":"2025-10-03","current":-1.72298,"twenty":-3.190715,"median":-0.990943,"eighty":-0.507809,"marketCap":77453103},{"date":"2025-10-10","current":-2.454316,"twenty":-3.178787,"median":-1.003032,"eighty":-0.508231,"marketCap":110328880},{"date":"2025-10-15","current":-2.255988,"twenty":-3.178787,"median":-1.01194,"eighty":-0.50825,"marketCap":101413415}],"updateTime":1760621828335},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNTB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2571635390","title":"Buy Rating for Connect Biopharma: Promising Clinical Data and Market Potential for Rademikibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2571635390","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571635390?lang=en_us&edition=fundamental","pubTime":"2025-09-29 23:55","pubTimestamp":1759161354,"startTime":"0","endTime":"0","summary":"Analyst Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings and keeping the price target at $7.00. Brandon Fo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-connect-biopharma-promising-clinical-data-and-market-potential-for-rademikibart-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-connect-biopharma-promising-clinical-data-and-market-potential-for-rademikibart-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2571339711","title":"Connect Biopharma presents data on rademikibart at ERS Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2571339711","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571339711?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:21","pubTimestamp":1759152077,"startTime":"0","endTime":"0","summary":"Connect Biopharma (CNTB) Holdings presented data supporting rademikibart, the Company’s investigational, next-generation, potentially best-in-class...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-presents-data-on-rademikibart-at-ers-congress-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-presents-data-on-rademikibart-at-ers-congress-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2571336758","title":"Connect Biopharma Announces Promising Phase 2 Data for Rademikibart in Asthma and COPD, with Topline Results Expected in 1H 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2571336758","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571336758?lang=en_us&edition=fundamental","pubTime":"2025-09-29 21:00","pubTimestamp":1759150841,"startTime":"0","endTime":"0","summary":"Connect Biopharma Announces Promising Phase 2 Data for Rademikibart in Asthma and COPD, with Topline Results Expected in 1H 2026. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on September 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250929:nNDLhnd0Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","CNTB","LU2095319765.USD","BK4139","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4585"],"gpt_icon":0},{"id":"2567483693","title":"Connect Biopharma Executives Increase Share Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2567483693","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567483693?lang=en_us&edition=fundamental","pubTime":"2025-09-16 21:26","pubTimestamp":1758029202,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings ( ($CNTB) ) has issued an announcement. Between September 2024 and September 2025, Barry D. Quart, CEO and Director of C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-executives-increase-share-holdings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/connect-biopharma-executives-increase-share-holdings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2564949543","title":"BRIEF-Connect Biopharma Completes Termination Of Its American Depositary Receipt Program And Directly Lists Its Ordinary Shares On Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2564949543","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564949543?lang=en_us&edition=fundamental","pubTime":"2025-09-03 22:33","pubTimestamp":1756910017,"startTime":"0","endTime":"0","summary":"BRIEF-Connect Biopharma Completes Termination Of Its American Depositary Receipt Program And Directly Lists Its Ordinary Shares On NasdaqConnect Biopharma Holdings Ltd CNTB.O:CONNECT BIOPHARMA COMPLET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nFWN3UQ0HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2564339566","title":"Connect Biopharma Unveils Rademikibart's Promising Potential for Asthma and COPD Treatment in Latest Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2564339566","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564339566?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:40","pubTimestamp":1756903217,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has released a corporate presentation detailing its recent advancements and strategic focus areas. The company is advancing its next-generation anti-interleukin-4-receptor alpha  treatment, Rademikibart, targeted at eosinophilic-driven respiratory diseases. Rademikibart is positioned as a promising option for the treatment of acute exacerbations in asthma and COPD, with market research highlighting its potential advantage over existing biologics like dupilumab. The company has initiated parallel Phase 2 studies for this purpose, with topline data expected in the first half of 2026. Connect Biopharma holds global development and commercialization rights for Rademikibart outside of greater China. The company anticipates significant commercial opportunities, with projected worldwide peak sales exceeding $3 billion for asthma and $2 billion for COPD. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL4TYCX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2564938183","title":"Connect Biopharma Completes Termination of Its American Depositary Receipt Program and Directly Lists Its Ordinary Shares on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2564938183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564938183?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:08","pubTimestamp":1756901314,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nFWN3UQ0HL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"gpt_icon":0},{"id":"2564398475","title":"Connect Biopharma Holdings Ltd. Transitions to Direct Nasdaq Listing, Enhancing U.S. Market Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2564398475","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564398475?lang=en_us&edition=fundamental","pubTime":"2025-09-03 20:00","pubTimestamp":1756900817,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has transitioned from an American Depositary Receipt  program to directly listing its ordinary shares on the Nasdaq Global Market. As of September 3, 2025, the company's ordinary shares began trading on Nasdaq under the symbol \"CNTB\". The ADRs were exchanged for ordinary shares at a one-for-one ratio.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on September 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250903:nNDL7NK2yX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU0314104364.USD","BK4112","NDAQ","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","BK4585","BK4588","CNTB","BK4139"],"gpt_icon":0},{"id":"2562474124","title":"Connect Biopharma Holdings Ltd. to Participate in Cantor Global Healthcare and H.C. Wainwright Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2562474124","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562474124?lang=en_us&edition=fundamental","pubTime":"2025-08-27 21:11","pubTimestamp":1756300292,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. , a clinical-stage biopharmaceutical company focused on inflammatory diseases, will participate in two upcoming investor conferences. The company will present at the Cantor Global Healthcare Conference on September 3rd, 2025, at 3:20 p.m. ET, and at the H.C. Wainwright 27th Annual Global Investment Conference on September 8th, 2025, at 9:30 a.m. ET. Both presentations will be in the format of a fireside chat.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on August 27, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nNDL2gyQxk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","IE00B3QW5Z07.USD","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","LU2095319765.USD","BK4112","LU2210150020.SGD","BK4139","BK4588","IE00BKPKM429.USD","LU0314104364.USD"],"gpt_icon":0},{"id":"2559985214","title":"Connect Biopharma Price Target Maintained With a $7.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2559985214","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559985214?lang=en_us&edition=fundamental","pubTime":"2025-08-14 01:44","pubTimestamp":1755107040,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 13, 2025 13:44 ET (17:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB"],"gpt_icon":0},{"id":"2559607300","title":"Connect Biopharma Hldgs Q2 EPS $(0.23) Misses $(0.22) Estimate, Sales $48.000K Down From $24.116M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2559607300","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559607300?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:14","pubTimestamp":1755090872,"startTime":"0","endTime":"0","summary":"Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.22) by 4.55 percent. This is a 185.19 percent decrease over earnings of $0.27 per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47089331/connect-biopharma-hldgs-q2-eps-0-23-misses-0-22-estimate-sales-48-000k-down-from-24-116m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB"],"gpt_icon":0},{"id":"2559960799","title":"Connect Biopharma Holdings Ltd. Submits New Drug Application for Rademikibart for AD Treatment to China's NMPA","url":"https://stock-news.laohu8.com/highlight/detail?id=2559960799","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559960799?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:04","pubTimestamp":1755090249,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has announced a significant milestone in its regulatory efforts, with the submission of a new drug application for rademikibart for the treatment of atopic dermatitis  to China's National Medical Products Administration . This submission was made by Simcere, Connect Biopharma's exclusive licensee in Greater China. The application marks an important step in bringing rademikibart, a promising treatment with demonstrated efficacy and safety for eosinophilic-driven type 2 asthma and COPD, closer to market availability in the region. As the review process progresses, Connect Biopharma continues to advance its clinical programs, including ongoing Phase 2 studies for asthma and COPD.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL2mYj0j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2559960732","title":"Connect Biopharma Initiates Phase 2 Seabreeze STAT Studies for Asthma and COPD, Showcasing Promising Data on Rademikibart's Efficacy and Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2559960732","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559960732?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:01","pubTimestamp":1755090072,"startTime":"0","endTime":"0","summary":"Connect Biopharma Initiates Phase 2 Seabreeze STAT Studies for Asthma and COPD, Showcasing Promising Data on Rademikibart's Efficacy and Safety. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on August 13, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9bcy9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","BK4112","CNTB","LU2095319765.USD","BK4139","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD","BK4585"],"gpt_icon":0},{"id":"2559607359","title":"Connect Biopharma Holdings Ltd - Q2 EPS $-0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2559607359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559607359?lang=en_us&edition=fundamental","pubTime":"2025-08-13 21:00","pubTimestamp":1755090002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nTUA92VK5M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"gpt_icon":0},{"id":"2553725666","title":"Connect Biopharma Holdings Ltd. Appoints Industry Veteran Jim Schoeneck to Board of Directors, Expanding Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2553725666","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553725666?lang=en_us&edition=fundamental","pubTime":"2025-07-22 21:00","pubTimestamp":1753189219,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has announced the expansion of its Board of Directors from six to seven members, appointing industry veteran Jim Schoeneck as a new director. Schoeneck brings over 40 years of experience in developing and commercializing medicines, and he currently serves as Chairman of the Board of Directors for FibroGen, Inc. and Calidi Biotherapeutics, Inc. His appointment is expected to aid in advancing the development and commercialization of rademikibart, a treatment for asthma and COPD.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on July 22, 2025, and is solely responsible for the information conta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250722:nNDLbll9K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CLDI","LU2095319765.USD","IE00BGHQF748.EUR","FGEN","NDAQ","IE00B64PRP62.GBP","BK4139","BK4585","BK4588","LU2210150020.SGD","LU2210149790.SGD","BK4505","BK4112","IE00BKPKM429.USD","IE00B3QW5Z07.USD","CNTB"],"gpt_icon":0},{"id":"2553047233","title":"Connect Biopharma Holdings Ltd. to Terminate ADR Program and Directly List Ordinary Shares on Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2553047233","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553047233?lang=en_us&edition=fundamental","pubTime":"2025-07-21 21:00","pubTimestamp":1753102812,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. has announced plans to terminate its American Depositary Receipt  program and directly list its ordinary shares on the Nasdaq Global Market. The transition will involve exchanging ADRs for ordinary shares at a one-for-one ratio. The company's ordinary shares will trade on Nasdaq under the symbol \"CNTB\" following the expected termination of the ADR program on or about September 2, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on July 21, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250721:nNDL4yPY2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","LU2210149790.SGD","BK4139","BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4112","IE00B3QW5Z07.USD","NDAQ","LU2095319765.USD","CNTB","IE00B64PRP62.GBP","BK4588"],"gpt_icon":0},{"id":"2552498549","title":"Connect Biopharma Holdings Ltd. to Participate in BTIG Virtual Biotechnology Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2552498549","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552498549?lang=en_us&edition=fundamental","pubTime":"2025-07-18 21:00","pubTimestamp":1752843610,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd., a clinical-stage biopharmaceutical company focused on inflammatory diseases, will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, July 29th, 2025, at 9:20 a.m. ET. The live webcast will be accessible on the company's website, with an archived replay available for 90 days post-event.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on July 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250718:nNDL1dN9TW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","BK4112","LU2210149790.SGD","LU2210150020.SGD","NDAQ","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","CNTB","BK4588","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2552481246","title":"Connect Biopharma Regains Nasdaq Compliance with Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2552481246","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552481246?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:00","pubTimestamp":1752757220,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd. announced on July 17, 2025, that it has regained compliance with the Nasdaq minimum bid price requirement. The biopharmaceutical company, focused on treatments for inflammatory diseases, confirmed that its American Depositary Shares maintained a minimum closing bid price of at least $1.00 for 10 consecutive business days, as of July 15, 2025. This compliance allows the company's shares to continue being listed and traded on Nasdaq, resolving the regulatory issue.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via GlobeNewswire  on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL10VLHr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","LU2210149790.SGD","IE00BGHQF748.EUR","CNTB","NDAQ","IE00B64PRP62.GBP","BK4112","IE00B3QW5Z07.USD","BK4139","BK4588","IE00BKPKM429.USD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2550630162","title":"Connect Biopharma's Partner Simcere Submits New Drug Application for Rademikibart for Atopic Dermatitis Treatment in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2550630162","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550630162?lang=en_us&edition=fundamental","pubTime":"2025-07-09 21:00","pubTimestamp":1752066026,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd., a clinical-stage biopharmaceutical company, has announced that its exclusive licensee in China, Simcere Pharmaceutical Co., Ltd., has submitted a New Drug Application for rademikibart to the National Medical Products Administration of China. This submission is for the treatment of atopic dermatitis in adults and adolescents. As part of their collaboration, Connect Biopharma is set to receive milestone payments and royalties based on net sales in Greater China. The application submission marks a significant step forward in bringing a potentially transformative treatment for atopic dermatitis to the Chinese market, addressing the needs of an estimated 70 million patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDL6KmGg0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BGHQF748.EUR","BK4112","BK4588","IE00BKPKM429.USD","LU2210150020.SGD","NDAQ","02096","BK1191","LU2210149790.SGD","BK4139","BK1583","IE00B64PRP62.GBP","CNTB","IE00B3QW5Z07.USD","BK4585"],"gpt_icon":0},{"id":"2543687843","title":"Connect Biopharma Unveils Promising Data for Rademikibart in Asthma and COPD Phase 2 Studies, Topline Results Expected 1H26","url":"https://stock-news.laohu8.com/highlight/detail?id=2543687843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543687843?lang=en_us&edition=fundamental","pubTime":"2025-06-13 21:00","pubTimestamp":1749819628,"startTime":"0","endTime":"0","summary":"SAN DIEGO, June 13, 2025  -- Connect Biopharma Holdings Limited , a clinical-stage biopharmaceutical company, has announced the presentation of clinical data supporting their investigational drug, rademikibart, at the European Academy of Allergy and Clinical Immunology  2025 Annual Congress. The data, which demonstrates rademikibart's potential to significantly improve lung function and reduce annualized exacerbations in patients with eosinophilic-driven type 2 asthma, will be available from June 13-16, 2025, in Glasgow, United Kingdom, and virtually. These findings support ongoing Phase 2 acute exacerbation studies in asthma and chronic obstructive pulmonary disease , with topline data expected in the first half of 2026. Presentations are accessible on Connect Biopharma's website under the presentations and publications section.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely inf","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250613:nNDL2XcTqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","CNTB","BK4112","BK4588","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","BK4139","LU2210150020.SGD","LU2210149790.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}